Akorn

Akorn is a pharmaceutical company that specializes in the development, manufacture, and marketing of both generic and branded prescription pharmaceuticals. The company operates primarily in the United States and internationally, focusing on several therapeutic areas, including ophthalmology, antidotes, anti-infectives, and controlled substances for pain management and anesthesia. Akorn's operations are divided into two main segments: Prescription Pharmaceuticals and Consumer Health. The Prescription Pharmaceuticals segment includes a variety of products such as sterile ophthalmics, injectables, inhalants, non-sterile oral liquids, topicals, and nasal sprays. In contrast, the Consumer Health segment encompasses animal health products and over-the-counter items, available under both branded and private-label formats. The majority of Akorn's revenue is generated from its Prescription Pharmaceuticals segment.

Robert Monahan

Senior Vice President of Corporate Development

2 past transactions

VersaPharm

Acquisition in 2014
VersaPharm is a developer and marketer of generic pharmaceuticals focused on niche markets within the United States. The company offers a diverse portfolio of specialty prescription products targeting various therapeutic areas, including tuberculosis, hemophilia, anthrax, parkinsonism, and blood disorders. With a commitment to maintaining strong customer relationships, VersaPharm distributes its products to major drug store chains, government entities, public health clinics, managed care providers, hospitals, and independent retail pharmacies. The company's extensive reach includes supply to federal, state, city, and county governments, ensuring a broad market presence in the healthcare sector.

Hi-Tech Pharmacal

Acquisition in 2013
Dynamic and growing, Hi-Tech Pharmacal is a specialty pharmaceutical company that develops, manufactures and markets generic and branded prescription and OTC products. We specialize in difficult-to-manufacture liquid and semi-solid dosage forms and offer a wide range of sterile ophthalmic, otic and inhalation products. The Generic Sales Division forms Hi-Tech's core business. The Company is dedicated to its continued growth and is strengthened through its other sales and marketing divisions: Health Care Products Division > a leading developer and marketer of branded OTC products for the diabetes, pain and allergy markets. ECR Pharmaceuticals > markets branded prescription products.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.